UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 250

Sortiert nach

Population-based differences in treatment outcome following anticancer drug therapies

The lancet oncology, 2010, Vol.11 (1), p.75-84

2010

Link zum Volltext

Verfügbarkeit prüfen

Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interference

Clinical epigenetics, 2023-03, Vol.15 (1), p.36-36, Article 36

2023

Link zum Volltext

Verfügbarkeit prüfen

Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma

Clinical chemistry (Baltimore, Md.), 2008-09, Vol.54 (9), p.1528-1536

2008

Link zum Volltext

Verfügbarkeit prüfen

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients

Proceedings of the National Academy of Sciences - PNAS, 2015-03, Vol.112 (11), p.E1317-E1325

2015

Link zum Volltext

Verfügbarkeit prüfen

Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?

Cancers, 2023-02, Vol.15 (4), p.1068

2023

Link zum Volltext

Verfügbarkeit prüfen

A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma

Cancer, 2012-08, Vol.118 (16), p.3984-3992

2012

Link zum Volltext

Verfügbarkeit prüfen

Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis

Journal of experimental & clinical cancer research, 2019-08, Vol.38 (1), p.359-359, Article 359

2019

Link zum Volltext

Verfügbarkeit prüfen

Personalized medicine in lung cancer: what we need to know

Nature reviews. Clinical oncology, 2011-11, Vol.8 (11), p.661-668

Mok, Tony S. K

2011

Link zum Volltext

Verfügbarkeit prüfen

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations

Journal of clinical oncology, 2013-09, Vol.31 (27), p.3342-3350

2013

Link zum Volltext

Verfügbarkeit prüfen

Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non - Small Cell Lung Cancer Patients

Clinical cancer research, 2009-03, Vol.15 (6), p.2076-2084

2009

Link zum Volltext

Verfügbarkeit prüfen

A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score

MedComm (2020), 2024-03, Vol.5 (3), p.e493-n/a

2024

Link zum Volltext

Verfügbarkeit prüfen

MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis

Clinical cancer research, 2016-06, Vol.22 (12), p.3048-3056

2016

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Journal of clinical oncology, 2009-02, Vol.27 (4), p.605-611

2009

Link zum Volltext

Verfügbarkeit prüfen

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

Journal of thoracic oncology, 2013-07, Vol.8 (7), p.883-891

2013

Link zum Volltext

Verfügbarkeit prüfen

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials

JAMA oncology, 2023-04, Vol.9 (4), p.527

2023

Link zum Volltext

Verfügbarkeit prüfen

Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1

Journal of molecular medicine (Berlin, Germany), 2015-11, Vol.93 (11), p.1221-1233

2015

Link zum Volltext

Verfügbarkeit prüfen

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Journal of clinical oncology, 2009-10, Vol.27 (30), p.5080-5087

2009

Link zum Volltext

Verfügbarkeit prüfen

Genotype-Specific Genomic Markers Associated with Primary Hepatomas, Based on Complete Genomic Sequencing of Hepatitis B Virus

Journal of Virology, 2008-04, Vol.82 (7), p.3604-3611

2008

Link zum Volltext

Verfügbarkeit prüfen

Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells

Journal of molecular medicine (Berlin, Germany), 2010-12, Vol.88 (12), p.1265-1276

2010

Link zum Volltext

Verfügbarkeit prüfen

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Journal of clinical oncology, 2009-01, Vol.27 (3), p.446-452

2009

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy

Hepatology (Baltimore, Md.), 2007-06, Vol.45 (6), p.1382-1389

2007

Link zum Volltext

Verfügbarkeit prüfen

De-novo and acquired resistance to immune checkpoint targeting

The lancet oncology, 2017-12, Vol.18 (12), p.e731-e741

2017

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 250

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(237)
Mit Volltextzugriff
(234)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(182)
Life Sciences & Biomedicine
(177)
Humans
(166)
Oncology
(127)
Female
(93)
Male
(88)
Middle Aged
(85)
Aged
(71)
Adult
(65)
Lung Neoplasms - Drug Therapy
(57)
Tumors
(55)
Biological And Medical Sciences
(53)
Medical Sciences
(52)
Lung Cancer
(51)
Carcinoma, Non-Small-Cell Lung - Drug Therapy
(48)
Lung Neoplasms - Pathology
(45)
Mutation
(42)
Chemotherapy
(37)
Lung Neoplasms - Genetics
(37)
Treatment Outcome
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Population-based differences in treatment outcome following anticancer drug therapies

Selenite as a dual apoptotic and ferroptotic agent synergizes with EGFR and KRAS inhibitors with epigenetic interference

Atezolizumab plus bevacizumab and chemotherapy in non-small-cell lung cancer (IMpower150): key subgroup analyses of patients with EGFR mutations or baseline liver metastases in a randomised, open-label phase 3 trial

Quantitative Analysis of Circulating Methylated DNA as a Biomarker for Hepatocellular Carcinoma

Lengthening and shortening of plasma DNA in hepatocellular carcinoma patients

Transbronchial Techniques for Lung Cancer Treatment: Where Are We Now?

A study of circulating interleukin 10 in prognostication of unresectable hepatocellular carcinoma

Ambient fine particulate matter inhibits 15-lipoxygenases to promote lung carcinogenesis

Personalized medicine in lung cancer: what we need to know

Symptom Control and Quality of Life in LUX-Lung 3: A Phase III Study of Afatinib or Cisplatin/Pemetrexed in Patients With Advanced Lung Adenocarcinoma With EGFR Mutations

Biomarker Analyses and Final Overall Survival Results From a Phase III, Randomized, Open-Label, First-Line Study of Gefitinib Versus Carboplatin/Paclitaxel in Clinically Selected Patients With Advanced Non–Small-Cell Lung Cancer in Asia (IPASS)

Gefitinib plus chemotherapy versus placebo plus chemotherapy in EGFR -mutation-positive non-small-cell lung cancer after progression on first-line gefitinib (IMPRESS): a phase 3 randomised trial

Single-Molecule Detection of Epidermal Growth Factor Receptor Mutations in Plasma by Microfluidics Digital PCR in Non - Small Cell Lung Cancer Patients

A novel approach to evaluation of tumor response for advanced pulmonary adenocarcinoma using the intertumoral heterogeneity response score

MET Amplification and Exon 14 Splice Site Mutation Define Unique Molecular Subgroups of Non-Small Cell Lung Carcinoma with Poor Prognosis

Hepatitis B Virus Reactivation in Lymphoma Patients With Prior Resolved Hepatitis B Undergoing Anticancer Therapy With or Without Rituximab

Detection of ALK Rearrangement by Immunohistochemistry in Lung Adenocarcinoma and the Identification of a Novel EML4-ALK Variant

Association of Immune-Related Adverse Events With Efficacy of Atezolizumab in Patients With Non-Small Cell Lung Cancer: Pooled Analyses of the Phase 3 IMpower130, IMpower132, and IMpower150 Randomized Clinical Trials

Estrogen receptor alpha promotes smoking-carcinogen-induced lung carcinogenesis via cytochrome P450 1B1

Randomized, Placebo-Controlled, Phase II Study of Sequential Erlotinib and Chemotherapy As First-Line Treatment for Advanced Non–Small-Cell Lung Cancer

Genotype-Specific Genomic Markers Associated with Primary Hepatomas, Based on Complete Genomic Sequencing of Hepatitis B Virus

Anticancer efficacy of 5F in NNK-induced lung cancer development of A/J mice and human lung cancer cells

New Utility of an Old Marker: Serial α-Fetoprotein Measurement in Predicting Radiologic Response and Survival of Patients With Hepatocellular Carcinoma Undergoing Systemic Chemotherapy

Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy

De-novo and acquired resistance to immune checkpoint targeting

Suchergebnisse filtern